Chronic inflammation after splenectomy is a risk factor for increased thrombotic cardiovascular events

被引：0

作者：

Gerges, M. ^{[1
]}

Gerges, C. ^{[1
]}

Seidl, V. ^{[1
]}

Eichelberger, B. ^{[2
]}

Lechner, K. ^{[3
]}

Alimohammadi, A. ^{[1
]}

Bonderman, D. ^{[1
]}

Frey, M. K. ^{[1
]}

Hofbauer, T. ^{[1
]}

Humenberger, M. ^{[1
]}

Jakowitsch, J. ^{[1
]}

Panzer, S. ^{[2
]}

Lang, I. M. ^{[1
]}

机构：

[1] Med Univ Vienna, Div Cardiol, Dept Internal Med 2, Vienna, Austria

[2] Med Univ Vienna, Dept Blood Grp Serol & Transfus Med, Vienna, Austria

[3] Med Univ Vienna, Div Hematol, Dept Internal Med 1, Vienna, Austria

来源：

EUROPEAN HEART JOURNAL | 2016年 / 37卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P2853

引用

页码：587 / 587

页数：1

共 50 条

[31] Increased risk of cardiovascular events with coxibs and NSAIDs
Emery, P
Moore, A
Hawkey, C
LANCET, 2005, 365 (9470): : 1538 - 1538
[32] Is rosiglitazone associated with increased risk for cardiovascular events?
Hanefeld, M.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2007, 4 (12): : 648 - 649
[33] Is rosiglitazone associated with increased risk for cardiovascular events?
Markolf Hanefeld
Nature Clinical Practice Cardiovascular Medicine, 2007, 4 : 648 - 649
[34] The cyclooxygenase-2 specific inhibitor valdecoxib is not associated with an increased risk of cardiovascular thrombotic events in arthritis patients
White, WB
Verburg, KM
Whelton, A
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 525A - 525A
[35] ANY INFECTION IS A RISK FACTOR FOR FUTURE CARDIOVASCULAR EVENTS IN CHRONIC KIDNEY DISEASE
Hassan, Hicham I. Cheikh
Tang, Mila
Djurdjev, Ognjenka
Levin, Adeera
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
[36] Homocysteine: A risk factor for the development of cardiovascular events in chronic respiratory diseases.
Avci, Gulcin Alp
Avci, Emre
BIOMEDICAL RESEARCH-INDIA, 2016, 27 : S450 - S453
[37] The cyclooxygenase-2 specific inhibitor, valdecoxib, is not associated with an increased risk of cardiovascular thrombotic events in arthritis patients
White, WB
Verburg, KM
Whelton, A
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 277 - 277
[38] Patients with vascular calcifications are at increased risk of cardiovascular events: implications for risk factor management and further research
Iribarren, C.
JOURNAL OF INTERNAL MEDICINE, 2007, 261 (03) : 235 - 237
[39] Cardiovascular thrombotic events are not increased on the cyclooxygenase-2 inhibitor celecoxib.
White, WB
Faich, G
Borer, JS
Makuch, R
ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S211 - S211
[40] Inflammation as a risk factor for restenosis and cardiovascular complications after transcutaneous intracoronary interventions
Kremneva, L. V.
Semukhin, M. V.
Kuznetsov, V. A.
TERAPEVTICHESKII ARKHIV, 2006, 78 (03) : 89 - 95

← 1 2 3 4 5 →